Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 11,369,000 | 11,142,000 | 10,358,000 | 10,974,000 | 10,635,000 |
| Cost of Goods | 5,075,000 | 4,854,000 | 4,468,000 | 4,942,000 | 4,698,000 |
| Gross Profit | 6,294,000 | 6,288,000 | 5,890,000 | 6,032,000 | 5,937,000 |
| Operating Expenses | 4,237,000 | 4,236,000 | 4,197,000 | 4,121,000 | 4,078,000 |
| Operating Income | 2,057,000 | 2,052,000 | 1,693,000 | 1,911,000 | 1,859,000 |
| Interest Expense | 121,000 | 121,000 | 131,000 | 136,000 | 142,000 |
| Other Income | 244,000 | 219,000 | 216,000 | 255,000 | 223,000 |
| Pre-tax Income | 2,180,000 | 2,150,000 | 1,778,000 | 2,030,000 | 1,940,000 |
| Income Tax | 536,000 | 371,000 | 453,000 | -7,199,000 | 294,000 |
| Net Income Continuous | 1,644,000 | 1,779,000 | 1,325,000 | 9,229,000 | 1,646,000 |
| Net Income | $1,644,000 | $1,779,000 | $1,325,000 | $9,229,000 | $1,646,000 |
| EPS Basic Total Ops | 0.94 | 1.02 | 0.76 | 5.29 | 0.94 |
| EPS Basic Continuous Ops | 0.94 | 1.02 | 0.76 | 5.31 | 0.95 |
| EPS Diluted Total Ops | 0.94 | 1.01 | 0.76 | 5.26 | 0.94 |
| EPS Diluted Continuous Ops | 0.94 | 1.02 | 0.76 | 5.28 | 0.94 |
| EPS Diluted Before Non-Recurring Items | 1.30 | 1.26 | 1.09 | 1.34 | 1.21 |
| EBITDA(a) | $2,848,000 | $2,829,000 | $2,449,000 | $2,718,000 | $2,660,000 |